These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2835831)

  • 1. Blood copper in organophosphate-induced delayed polyneuropathy.
    Lotti M; Caroldi S; Moretto A
    Toxicol Lett; 1988 May; 41(2):175-80. PubMed ID: 2835831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organophosphate polyneuropathy and neuropathy target esterase: studies with methamidophos and its resolved optical isomers.
    Lotti M; Moretto A; Bertolazzi M; Peraica M; Fioroni F
    Arch Toxicol; 1995; 69(5):330-6. PubMed ID: 7654138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organophosphate polyneuropathy in chicks.
    Peraica M; Capodicasa E; Moretto A; Lotti M
    Biochem Pharmacol; 1993 Jan; 45(1):131-5. PubMed ID: 8381002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for organophosphate-induced delayed polyneuropathy.
    Moretto A
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.5. PubMed ID: 20957642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delayed polyneuropathy induced by organophosphorus esters].
    Lotti M
    Riv Neurobiol; 1982; 28(3-4):498-506. PubMed ID: 6195725
    [No Abstract]   [Full Text] [Related]  

  • 6. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
    Moretto A; Bertolazzi M; Lotti M
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
    Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicant sensitive esterase. Enzymology and pathophysiology of organophosphorus ester-induced delayed neuropathy.
    Zech R; Chemnitius JM
    Prog Neurobiol; 1987; 29(2):193-218. PubMed ID: 3035612
    [No Abstract]   [Full Text] [Related]  

  • 9. Organophosphate polyneuropathy: pathogenesis and prevention.
    Lotti M; Becker CE; Aminoff MJ
    Neurology; 1984 May; 34(5):658-62. PubMed ID: 6324035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride.
    Lotti M; Caroldi S; Capodicasa E; Moretto A
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):234-41. PubMed ID: 2017753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal degeneration and neuropathy target esterase.
    Glynn P
    Arh Hig Rada Toksikol; 2007 Sep; 58(3):355-8. PubMed ID: 18050888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathic insults.
    Moretto A; Bertolazzi M; Capodicasa E; Peraica M; Richardson RJ; Scapellato ML; Lotti M
    Arch Toxicol; 1992; 66(1):67-72. PubMed ID: 1316117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of verapamil on organophosphorus-induced delayed neuropathy in hens.
    el-Fawal HA; Jortner BS; Ehrich M
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):500-11. PubMed ID: 2558427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy.
    Lotti M; Moretto A; Zoppellari R; Dainese R; Rizzuto N; Barusco G
    Arch Toxicol; 1986 Oct; 59(3):176-9. PubMed ID: 2434058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
    Milatovic D; Moretto A; Osman KA; Lotti M
    Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the delayed neurotoxicity of tributyl phosphate, tributoxyethyl phosphate, and dibutylphenyl phosphate.
    Carrington CD; Lapadula DM; Othman M; Farr C; Nair RS; Johannsen F; Abou-Donia MB
    Toxicol Ind Health; 1990; 6(3-4):415-23. PubMed ID: 2237927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and clinical tests of the delayed neuropathic potential of some O-alkyl O-dichlorophenyl phosphoramidate analogues of methamidophos (O,S-dimethyl phosphorothioamidate).
    Johnson MK; Vilanova E; Read DJ
    Toxicology; 1989 Jan; 54(1):89-100. PubMed ID: 2536970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of peripheral axonopathies by certain esterase inhibitors.
    Moretto A; Lotti M
    Toxicol Ind Health; 1993; 9(6):1037-46. PubMed ID: 8191502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances.
    Johnson MK; Glynn P
    Toxicol Lett; 1995 Dec; 82-83():459-63. PubMed ID: 8597094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A key step forward in understanding the pathogenesis of organophosphate polyneuropathy.
    Lotti M
    Hum Exp Toxicol; 1995 Jan; 14(1):69-70. PubMed ID: 7748619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.